Cargando…

Subthreshold micropulse laser versus standard laser for the treatment of central-involving diabetic macular oedema with central retinal thickness of <400µ: a cost-effectiveness analysis from the DIAMONDS trial

OBJECTIVES: To estimate the economic costs, health-related quality-of-life outcomes and cost-effectiveness of subthreshold micropulse laser (SML) versus standard laser (SL) for the treatment of diabetic macular oedema (DMO) with central retinal thickness (CRT) of <400µ. DESIGN: An economic evalua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mistry, Hema, Maredza, Mandy, Campbell, Christina, Lois, Noemi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Health Economics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603454/ https://www.ncbi.nlm.nih.gov/pubmed/37852765 http://dx.doi.org/10.1136/bmjopen-2022-067684

Ejemplares similares

Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial
por: Lois, Noemi, et al.
Publicado: (2019)

Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy
por: Abd Elhamid, Ahmed Hosni
Publicado: (2015)

Subthreshold 577 nm micropulse laser treatment for central serous chorioretinopathy
por: Maruko, Ichiro, et al.
Publicado: (2017)

A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders
por: Scholz, Paula, et al.
Publicado: (2017)

Commentary: Subthreshold micropulse yellow laser in diabetic macular edema
por: Bansal, Mayank
Publicado: (2020)

Subthreshold Micropulse Laser for Diabetic Macular Edema: A Review
por: Sabal, Barbara, et al.
Publicado: (2022)

Efficacy and safety of subthreshold micropulse laser compared with threshold conventional laser in central serous chorioretinopathy
por: Sun, Zuhua, et al.
Publicado: (2019)

532-nm Subthreshold Micropulse Laser for the Treatment of Chronic Central Serous Retinopathy
por: Sousa, Keissy, et al.
Publicado: (2020)

Surveillance of people with previously successfully treated diabetic macular oedema and proliferative diabetic retinopathy by trained ophthalmic graders: cost analysis from the EMERALD study
por: Maredza, Mandy, et al.
Publicado: (2022)

Intravitreal Dexamethasone Implant (IDI) Alone and Combined with Navigated 577 nm Subthreshold Micropulse Laser (SML) for Diabetic Macular Oedema
por: Toto, Lisa, et al.
Publicado: (2022)

OCT biomarkers related to subthreshold micropulse laser treatment effect in central serous chorioretinopathy
por: Zheng, Fang, et al.
Publicado: (2022)

Commentary: Subthreshold micropulse yellow laser for central serous chorioretinopathy: Finding the right protocol
por: Saurabh, Kumar, et al.
Publicado: (2022)

Subthreshold Micropulse Laser Modulates Retinal Neuroinflammatory Biomarkers in Diabetic Macular Edema
por: Frizziero, Luisa, et al.
Publicado: (2021)

Subthreshold Micropulse Laser vs. Conventional Laser for Central Serous Chorioretinopathy: A Randomized Controlled Clinical Trial
por: Zhou, Lijun, et al.
Publicado: (2021)

Increase in Central Retinal Edema after Subthreshold Diode Micropulse Laser Treatment of Chronic Central Serous Chorioretinopathy
por: Gawęcki, Maciej
Publicado: (2015)

Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser
por: Gawęcki, Maciej, et al.
Publicado: (2017)

Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy
por: Zeng, Miao, et al.
Publicado: (2022)

577 nm subthreshold micropulse laser treatment for acute central serous chorioretinopathy: a comparative study
por: Long, He, et al.
Publicado: (2022)

Comparison of two protocols of subthreshold micropulse yellow laser treatment for non-resolving central serous chorioretinopathy
por: Beniwal, Abhijeet, et al.
Publicado: (2022)

Functional Outcomes and Safety Profile of Trans-Foveal Subthreshold Micropulse Laser in Persistent Central Serous Chorioretinopathy
por: Kiraly, Peter, et al.
Publicado: (2023)

A Review of Subthreshold Micropulse Laser and Recent Advances in Retinal Laser Technology
por: Su, Daniel, et al.
Publicado: (2017)

Effects of subthreshold diode micropulse laser photocoagulation on treating patients with refractory diabetic macular edema
por: Akhlaghi, Mohammadreza, et al.
Publicado: (2018)

Role of 532 nm transfoveal subthreshold micropulse laser in non-resolving central serous chorioretinopathy with subfoveal leaks
por: Ambiya, Vikas, et al.
Publicado: (2020)

The Short-term Efficacy of Subthreshold Micropulse Yellow (577-nm) Laser Photocoagulation for Diabetic Macular Edema
por: Kwon, Yoon Hyung, et al.
Publicado: (2014)

Aqueous humour concentrations of PEDF and Erythropoietin are not influenced by subthreshold micropulse laser treatment of diabetic macular edema
por: Midena, Edoardo, et al.
Publicado: (2019)

Subthreshold Micropulse Laser in Diabetic Macular Edema: 1-Year Improvement in OCT/OCT-Angiography Biomarkers
por: Vujosevic, Stela, et al.
Publicado: (2020)

The Role of Subthreshold Micropulse Yellow Laser as an Alternative Option for the Treatment of Refractory Postoperative Cystoid Macular Edema
por: Verdina, Tommaso, et al.
Publicado: (2020)

Comparison of subthreshold diode laser micropulse therapy versus conventional photocoagulation laser therapy as primary treatment of diabetic macular edema
por: Fazel, Farhad, et al.
Publicado: (2016)

Comparison of short-pulse subthreshold (532 nm) and infrared micropulse (810 nm) macular laser for diabetic macular edema
por: Al-Barki, Abdulrahman, et al.
Publicado: (2021)

Low-Fluence Photodynamic Therapy versus Subthreshold Micropulse Yellow Wavelength Laser in the Treatment of Chronic Central Serous Chorioretinopathy
por: Özmert, Emin, et al.
Publicado: (2016)

Subthreshold Diode Micropulse Laser Photocoagulation (SDM) as Invisible Retinal Phototherapy for Diabetic Macular Edema: A Review
por: Luttrull, Jeffrey K, et al.
Publicado: (2012)

Subthreshold diode-laser micropulse photocoagulation as a primary and secondary line of treatment in management of diabetic macular edema
por: Othman, Ihab Saad, et al.
Publicado: (2014)

Subthreshold Micropulse Yellow Laser (577 nm) for Idiopathic Macular Telangiectasia Type 1 Resistant to Intravitreal Injection
por: Kang, Yong Koo, et al.
Publicado: (2020)

Subthreshold Diode Micropulse Laser Combined with Intravitreal Therapy for Macular Edema—A Systematized Review and Critical Approach
por: Gawęcki, Maciej
Publicado: (2021)

Anatomical and functional outcomes of subthreshold micropulse laser versus intravitreal ranibizumab injection in treatment of diabetic macular edema
por: Abdelrahman, Amr, et al.
Publicado: (2020)

Yellow Subthreshold Micropulse Laser in Retinal Diseases: An In-Depth Analysis and Review of the Literature
por: Iovino, Claudio, et al.
Publicado: (2023)

Comparison of the efficacy and safety of subthreshold micropulse laser with photodynamic therapy for the treatment of chronic central serous chorioretinopathy: A meta-analysis
por: Wu, Zhizhong, et al.
Publicado: (2021)

Subthreshold Diode Micropulse Laser (SDM) for Persistent Macular Thickening and Limited Visual Acuity After Epiretinal Membrane Peeling
por: Luttrull, Jeffrey K
Publicado: (2020)

Efficacy and Safety of Subthreshold Micropulse Yellow Laser for Persistent Diabetic Macular Edema After Vitrectomy: A Pilot Study
por: Bonfiglio, Vincenza, et al.
Publicado: (2022)

Diabetic Macular Edema Treated with 577-nm Subthreshold Micropulse Laser: A Real-Life, Long-Term Study
por: Frizziero, Luisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mggu499at3tbbn49rf865elnfj